Vitamin D and Resistance Exercise in Elderly (NUTRIAGINGVitD)
- Conditions
- Aging
- Interventions
- Other: Strength Training and no Vitamin DOther: Strength Training and Vitamin D monthlyOther: Strength Training and Vitamin D daily
- Registration Number
- NCT04341818
- Lead Sponsor
- University of Vienna
- Brief Summary
The aim of this randomized, double-blind, controlled intervention study with parallel groups is to investigate the effect of resistance training (2x/week for 10 weeks) with and without different goals of vitamin D intake on muscle strength, function and mass, oxidative stress parameters and the immune system in community dwelling persons. Participants (n = 100) will be community-dwelling older adults. After a preparticipation screening and a vitamin D blood investigation (vitamin D status below 75 nmol/L) participants will be distributed randomly but stratified by sex, age and initial vitamin D plasma levels to one of the 3 groups (Vitamin D daily + strength training, Vitamin D monthly + strength training, no Vitamin D + strength training).
Study participants are eligible if they are male or female with an age between 65 and 85 years and if their cognitive status as well as their physical fitness level allows to participate at the strength training sessions. Exclusion criteria comprise chronic diseases which contraindicate the training sessions, serious cardiovascular disease, diabetic retinopathy and manifest osteoporosis, a frailty index at or above 3, medication with anticoagulants or cortisone drugs, a regular strength training during the last six months and a vitamin D plasma concentration of 75nmol/L or above.
Primary outcome measure is the change in the handgrip strength. Secondary outcome measures comprise anthropometric data, functional performance tests, immunological and oxidative stress parameters, DNA/Chromosomal damage microbiota, metabolomics and the nutritional status.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
- Males and females between the age of 65 and 85 years
- Adequate mental condition in order to follow the instructions and to perform the resistance exercise independently (Mini-Mental-State >23)
- Independently mobile
- Chronic diseases, which contraindicate a training participation
- Serious cardiovascular diseases (congestive chronic heart failure, severe or symptomatic aortic stenosis, unstable angina pectoris, untreated arterial hypertension, cardiac arrhythmias)
- Diabetic retinopathy
- Manifest osteoporosis
- Regular use of cortisone-containing drugs
- Regular strength training (> 1x / week) in the last 6 months before inclusion
- Vitamin D plasma level of 75 nmol/l or above
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Strength Training and no Vitamin D Strength Training and no Vitamin D Four weeks of no vitamin D administration followed by a 10 week guided resistance training (progressive strength training in a fitness center is applied; the intensity is adjusted continuously in order to obtain a sufficient training stimulus). During the training period the vitamin D intake remains. Over the whole study period participants get 400 mg calcium/day. Strength Training and Vitamin D monthly Strength Training and Vitamin D monthly Four weeks of Vitamin D (50.000 IU once per month) followed by a 10 week guided resistance training (progressive strength training in a fitness center is applied; the intensity is adjusted continuously in order to obtain a sufficient training stimulus). During the training period the vitamin D intake remains. Over the whole study period participants get 400 mg calcium/day. Strength Training and Vitamin D daily Strength Training and Vitamin D daily Four weeks of Vitamin D (800 IU once per day) followed by a 10 week guided resistance training (progressive strength training in a fitness center is applied; the intensity is adjusted continuously in order to obtain a sufficient training stimulus). During the training period the vitamin D intake remains. Over the whole study period participants get 400 mg calcium/day.
- Primary Outcome Measures
Name Time Method Change from baseline in handgrip strength (kg) baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks) Handgrip strength of the right hand will be measured to the nearest kilogram (kg) using a hand Dynamometer. Participants will be encouraged to perform a maximal contraction within approximately 4 to 5 s. After a rest of 60 s, participants will be asked to perform a second trial. The highest score of maximum voluntary contraction will be used for data analyses.
- Secondary Outcome Measures
Name Time Method Change from baseline in the composition of gut-microbiota baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks) Gene sequencing of the 16S rRNA on the stool samples are performed to identify the microbes down to genus level as well as the microbial diversity and relative abundance.
Change from baseline in DNA damage (%DNA in the tail) baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks) DNA damage will be assessed in lymphocytes, whole blood and urine in response to the interventions.
Change from baseline in 6min walking test (distance in meter) baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks) Participants are instructed to walk alone as quickly as possible (without running) around a 30 m shuttle course as many times as possible within the time limit of 6 mins.
Change from baseline in oxidative stress marker such as malondialdehyde baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks) The investigators will consider changes in plasma concentrations of oxidative stress marker such as malondialdehyde.
Change from baseline in chromosomal damage (number of micronuclei/1000 binucleated cells) baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks) Chromosomal damage will be assessed in lymphocytes in response to the interventions.
Change from baseline in muscle mass with BIA (kg) baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks) Change from baseline in chair stand test (repetitions within 30s) baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks) The maximum number of completed cycles of unsupported chair rises (from a seated to a fully erected position (hip and knees straightened)) completed within 30 s is counted automatically (Leonardo Mechanography). Force, acceleration, power, kinetic energy, potential energy, mass, total duration, time per iteration are reported as secondary parameters.
Change from baseline in stool short-chain fatty acids (SCFAs) baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks) The stool short-chain fatty acids (SCFAs) will be extracted and quantitatively analysed by gas chromatography.
Change from baseline in inflammatory marker (i.g. IL-6, TNF-alpha) baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks) The investigators will consider changes in plasma concentrations of Interleukin 1 (IL-1), IL-6, IL-8, IL-10, TNF-alpha
Change from baseline in the metabolomic response baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks) The metabolomic response (ie all metabolites) to the interventions will be analyzed using both nuclear magnetic resonance (NMR) and mass spectrometry (MS) techniques. Patterns of metabolites will be evaluated with statistical techniques, ie discriminant analysis and principal component analysis.
Change from baseline in the amino acid pattern baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks) The plasma amino acid pattern will be assessed with HPLC-MS.
Change from baseline in RDA and DNA gene expression baseline, after dietary intervention (4 weeks) and after dietary intervention and strength training (14 weeks) RNA and DNA gene expression will be assessed in response to the interventions.
Trial Locations
- Locations (1)
University of Vienna
🇦🇹Vienna, Austria